Ruzasvir

Drug identity checked against registry records

Also recorded as AT-038

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Phase 2, Safety and Efficacy of Bemnifosbuvir (BEM) and Ruzasvir (RZR) in Subjects With Chronic HCVNCT05904470AVIRPhase 2Completed2024-12-09Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.